ClinConnect ClinConnect Logo
Search / Trial NCT04509401

Effects of High Dose of Vitamin B6 With Magnesium in Children With Autism Spectrum Disorder

Launched by BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY, DHAKA, BANGLADESH · Aug 9, 2020

Trial Information

Current as of July 21, 2025

Completed

Keywords

Vitamin B6 Magnesium Homovanillic Acid Adcl Asd

ClinConnect Summary

Autism spectrum Disorder is a complex neuro- developmental, incurable disease with lifelong impacts.Epidemiological studies have shown a rapid increase in the prevalence of ASD throughout the world including Bangladesh. The World Health Organization (WHO) estimated every 1 in 160 children has an autism spectrum disorder. Various environmental, genetic ,biochemical, metabolic factors are presumed to be involved in the etiology of ASD. Researchers found Vitamin B6 with Magnesium has the potential effects to alleviate the core symptoms of autism. A possible association higher doses of vitamin ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Newly diagnosed patients of Autism Spectrum Disorder Co-morbid neurological disorder like irritability, hyperactivity with ASD
  • -
  • Exclusion Criteria: Epilepsy

About Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Bangabandhu Sheikh Mujib Medical University (BSMMU) in Dhaka, Bangladesh, is a premier institution dedicated to advancing medical education, research, and healthcare services. As a leading clinical trial sponsor, BSMMU is committed to fostering innovative research initiatives that enhance patient care and contribute to the global medical community. The university boasts a multidisciplinary team of experts and state-of-the-art facilities, enabling the conduct of rigorous clinical trials across various therapeutic areas. With a focus on ethical standards and patient safety, BSMMU aims to facilitate the development of new treatments and improve health outcomes both locally and internationally.

Locations

Dhaka, , Bangladesh

Patients applied

0 patients applied

Trial Officials

Fatema Ershad, MBBS

Principal Investigator

BSMMU (Recruiting)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials